This cohort study evaluates eligibility for cardiovascular-kidney-metabolic medications in Euro

01 Mar 20264 min read0 viewsJournal Feed

GIST

JAMA Cardiology published a clinical update in Cardiology on 01 Mar 2026. The item focuses on Cardiovascular-Kidney-Metabolic Medication Eligibility. Review the original article for the full source wording and details.

Clinical Editorial

Summary

JAMA Cardiology published a clinical update in Cardiology on 01 Mar 2026.

The item focuses on Cardiovascular-Kidney-Metabolic Medication Eligibility.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

AHA NewsRelated by Specialty

La Universidad de Míchigan otorgó una subvención de la American Heart Association para la educación y el entrenamiento de RCP

Cardiology • 22 May 2026

AHA NewsRelated by Specialty

Una donación de $1 millón impulsará la investigación sobre los defectos cardíacos congénitos

Cardiology • 22 May 2026

JAHARelated by Specialty

Study Design and Conceptual Framework of an Observational Study of Food Insecurity and Life's Essential 8 in College Students: The FRESH Study

Cardiology • 29 Apr 2026

JAHARelated by Specialty

Coronary Embolism in Atrial Fibrillation: A Distinct High‐Risk Phenotype With Residual Thromboembolic Risk Despite Anticoagulation

Cardiology • 29 Apr 2026

Feed Metadata

Source

JAMA Cardiology